AP Insights, News, Videos, and More

The rate of methamphetamine-involved deaths in the United States increased 50-fold between 1999 and 2021, with polysubstance use involving heroin or fentanyl playing a major role, according to researchers from the University of Illinois...

A community-focused strategy developed by University of Pittsburgh researchers reduced opioid overdose deaths in participating counties by 30%, according to a new study.

A pill used to treat a common skin disease was found to reduce alcohol consumption by more than half among patients diagnosed with alcohol use disorder, according to findings published recently by researchers at Oregon Health & Science...

Drug tests positive for fentanyl across the US increased by 146% from 2019 to 2022, largely fueled by the western half of the nation, according to data from the Millennium Health Signals Report, which was released on Tuesday.

As Ashley Addiction Treatment celebrates its 40th anniversary, co-CEOs and presidents Alex Denstman and Greg Hobelmann, MD, MPH, reaffirm Ashley’s core values while advancing the organization—and substance use disorder treatment—forward.

About 13% of individuals between the ages of 50 and 80 show signs of addiction to highly processed foods, according to a new study from the University of Michigan Institute for Healthcare Policy and Innovation.

A year after unveiling his “Unity Agenda,” President Joe Biden on Tuesday night reaffirmed his administration’s commitment to addressing the nation’s mental health and addiction crisis and detailed new initiatives.

The short-term effects of vaporized cannabis do not differ between adolescents and adults, and CBD does not dampen the effects of the drug, according to a new study conducted in London.

Healthcare testing lab Aegis Science Corporation says it has found xylazine in its screenings of samples provided by patients from 25 states, indicating the animal tranquilizer has a more widespread presence in the US than previously thought.